Newborn Screening for CAH—Challenges and Opportunities

Abstract
Newborn screening for congenital adrenal hyperplasia (CAH) using 17-hydroxyprogesterone (17-OHP) as an indicator of disease was first introduced in the 1970s
Keywords

This publication has 10 references indexed in Scilit: